Drexo Pharma Private Limited - Company Profile

It is a trading private limited company based in Saharanpur, Uttar Pradesh, India, established in 2019.
2019 Saharanpur, Uttar Pradesh, India Active
Last Updated:
Access Report
About Drexo Pharma Private Limited

Drexo Pharma Private Limited, a active private limited company, was established on 09 October 2019 in Saharanpur, Uttar Pradesh, India. Engaging in specialty within the trading sector, it holds CIN: U51909UP2019PTC122122. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.75 M.

Its leadership includes Bhavam Gupta (Director), Kuldeep Gupta (Director). Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 75D, Baapu Ji Nagar, Itc Road, Near Park,, Saharanpur, Uttar Pradesh, 247001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51909UP2019PTC122122

  • Registration Number

    122122

  • Incorporation Date

    09 October 2019

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.75 M

  • ROC Code

    Roc Kanpur

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.75 M
  • Company Age 6 Year, 4 Months
  • Last Filing with ROC 31 Mar 2024
  • Revenue Growth **** 280.41%
  • Profit Growth **** 15.60%
  • Ebitda **** 118.00%
  • Net Worth 0.82%
  • Total Assets **** 60.25%
Company report

Drexo Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Drexo Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Drexo Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Bhavam Gupta Director 09 Oct 2019 Current
Kuldeep Gupta Director 09 Oct 2019 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Drexo Pharma.

Drexo Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 280.41% increase. The company also saw a substantial improvement in profitability, with a 15.6% increase in profit. The company's net worth moved up by a moderate rise of 0.82%.

Drexo Pharma revenue growth over time
Drexo Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 280.41%
*******
*******
*******
*******
Revenue from Operations
*******
 320.01%
*******
*******
*******
*******
Total Assets
*******
 60.25%
*******
*******
*******
*******
Profit or Loss
*******
 15.60%
*******
*******
*******
*******
Net Worth
*******
 0.82%
*******
*******
*******
*******
EBITDA
*******
 118.00%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Drexo Pharma?

Unlock access to Drexo Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Drexo Pharma?

Unlock and access historical data on people associated with Drexo Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Drexo Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Drexo Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Drexo Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Drexo Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on Drexo Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur. was documented.

  • Director Appointment

    Progress on Bhavam Gupta was appointed as a Director was appointed as a Director on 09 Oct 2019 & has been associated with this company since 6 years 4 months . was documented.

  • Director Appointment

    Progress on Kuldeep Gupta was appointed as a Director was appointed as a Director on 09 Oct 2019 & has been associated with this company since 6 years 4 months . was documented.

  • Company Incorporation

    The activity Drexo Pharma Private Limited was registered on 09 Oct 2019 with Roc Kanpur & aged 6 years 4 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Drexo Pharma Private Limited?

The CIN of Drexo Pharma Private Limited is U51909UP2019PTC122122.

Where is Drexo Pharma Private Limited headquartered?

Drexo Pharma Private Limited is headquartered at 75D, Baapu Ji Nagar, Itc Road, Near Park,, Saharanpur, Uttar Pradesh, 247001.

When was Drexo Pharma Private Limited incorporated?

Drexo Pharma Private Limited was incorporated on 09 October 2019.

Who are the current directors of Drexo Pharma Private Limited?

The current directors of Drexo Pharma Private Limited are

What is the primary industry of Drexo Pharma Private Limited?

The primary industry of Drexo Pharma Private Limited is Trading.

Is Drexo Pharma Private Limited a listed company?

Drexo Pharma Private Limited is unlisted.

What is the capital structure of Drexo Pharma Private Limited?

The authorized capital of Drexo Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹0.75 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available